am 580 has been researched along with silicon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertermann, R; Büttner, MW; Daiss, JO; Furst, A; Gaudon, C; Gronemeyer, H; Khanwalkar, H; Lippert, WP; Müller, V; Tacke, R | 1 |
| Hashimoto, Y; Matsumoto, Y; Nakagomi, M; Nakamura, M; Toyama, H | 1 |
2 other study(ies) available for am 580 and silicon
| Article | Year |
|---|---|
Synthesis and pharmacological characterization of Disila-AM80 (Disila-tamibarotene) and Disila-AM580, silicon analogues of the RARalpha-selective retinoid agonists AM80 (Tamibarotene) and AM580.
Topics: Antineoplastic Agents; Benzoates; HeLa Cells; Humans; Organosilicon Compounds; Phthalic Acids; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Silicon; Tetrahydronaphthalenes | 2009 |
Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors.
Topics: Anilides; Benzoates; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Nuclear Receptor Subfamily 1, Group F, Member 1; Organosilicon Compounds; Silicon; Structure-Activity Relationship; Tetrahydronaphthalenes | 2014 |